AW
Insider
Amy McBride Wendell
DirectorAmy McBride Wendell (Director) filed 3 Form 4 reports in the trailing twelve months (1 purchase, 2 sales), most often in Axogen, Inc. (AXGN). Across 1 priced purchase filing, the average 21-session return was -4.5% from execution and -2.2% from disclosure (delay-adjusted; derived). The largest single filing was $1.3M of AXGN (43,684 sh across 3 lots, as filed), executed Dec 16 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-4.5%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-2.2%
same 1 filings, from disclosure
Filings, ttm
3
1 buys · 2 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.0M
shares × price, as filed
Last traded
Aug 11
Filed Aug 12
Median ADV $60.7M across their filed names
Open performance→Volume by month
Buys $100K
Sells $2.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
AXGNRecent filings
AXGNSALE
Axogen, Inc.
View filing →
$647K13,353 sh × $48.42
Exec Aug 11
Filed Aug 12 · 4:12 PM ET SOLVPURCHASE Solventum Corporation View filing → $100K
1,475 sh × $68.03
Exec Mar 10
Filed Mar 11 · 6:31 AM ET AXGNSALE Axogen, Inc. View filing → $1.3M
43,684 sh across 3 lots
Exec Dec 16 2025
Filed Dec 17 2025 · 5:30 PM ET AXGNSALE Axogen, Inc. View filing → $100K
5,000 sh × $20.02
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET